SPDR S&P Pharmaceuticals ETF: (XPH)
(Delayed Data from NYSE) As of Apr 18, 2024 03:59 PM ET
$39.10 USD
-0.48 (-1.21%)
Volume: 11,397
After-Market: $39.00 -0.10 (-0.26 %) 7:38 PM ET
ETF Quote Details
Previous Close | 39.58 |
Open | 39.51 |
Bid | 39.10 |
Ask | 39.14 |
Day Low-High | 39.10-39.52 |
52wk Low-High | 34.67-45.48 |
Volume | 11,397 |
NAV (month end) | 43.13 |
Premium (+)/Discount (-) (month end) | -3.55 |
ETF Expense Ratio
Expense Ratio | 0.35% |
Dividend (Yield) | $0.59 (1.49%) |
Issuer | STATE STREET GLOBAL ADVISORS |
Benchmark for XPH
SP PHARMACEUTICALS SELECT INDUSTRY INDEX
The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the US common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Pharmaceuticals Index is a modified equal weight index.
Fund Summary for XPH
SPDR S&P PHARMACEUTICALS ETF
The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible, before expenses, the total return performance of the S&P Pharmaceuticals Select Industry Index.